Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Wendt, Frank R. http://orcid.org/0000-0002-2108-6822
Pathak, Gita A.
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Aslan, Mihaela
Quaden, Rachel
Harrington, Kelly M.
Nuñez, Yaira Z.
Overstreet, Cassie
Radhakrishnan, Krishnan
Sanacora, Gerard
McIntosh, Andrew M. http://orcid.org/0000-0002-0198-4588
Shi, Jingchunzi
Shringarpure, Suyash S.
Concato, John
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
,
,
Article History
Received: 13 May 2020
Accepted: 16 April 2021
First Online: 27 May 2021
Competing interests
: M.B.S. reports receiving consulting fees in the past 3 years from Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio Biosciences, EmpowerPharm, Engrail Therapeutics, Genentech/Roche, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals and Oxeia Biopharmaceuticals. In the last 12 months, G.S. has provided consulting services to Allergan, Axsome Therapeutics, Biohaven Pharmaceuticals, Boehringer Ingelheim International, Bristol-Myers Squibb, Clexio Biosciences, Epiodyne, Intra-Cellular Therapies, Janssen, Lundbeck, Minerva Pharmaceuticals, Navitor Pharmaceuticals, NeuroRX, Noven Pharmaceuticals, Otsuka, Perception Neuroscience, Praxis Seelos Pharmaceuticals and Vistagen Therapeutics. G.S. has received funds for contracted research from Janssen Pharmaceuticals, Merck and the Usona Institute. G.S. holds equity in Biohaven Pharmaceuticals and has received royalties from Yale University, paid from patent licenses with Biohaven Pharmaceuticals. J.S. and S.S. are employed by and hold stock or stock options in 23andMe, Inc. J.G. is named as co-inventor on Patent Cooperation Treaty application no. 15/878,640 titled ‘Genotype-guided dosing of opioid agonists’, filed on January 24, 2018. All other authors declare that they have no competing financial interests.